Clinical trial · Observational
Circulating Tumor Material in Colorectal Cancer and Melanoma
Protocol to Permit the Acquisition of Circulating Tumor Material in Colorectal Cancer and Melanoma
NCT02907086CI-TRIAL-00058915completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer and Melanoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- colorectal cancer
- interventionNames
- Other: blood collection
- label
- melanoma
- interventionNames
- Other: blood collection
Primary outcomes (1)
- measure
- Number of blood samples collected
- timeFrame
- 24 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * The subject must be a patient at the Hospital of the University of Pennsylvania 1. Patients with presumed stage II, III, or IV colorectal cancer with planned surgical resection of either the primary tumor or metastatic lesion(s) being evaluated at the Hospital of the University of Pennsylvania 2. Patients with histologically confirmed melanoma stage IIb, IIc, IIIa, IIIb, or IIIc/IV scheduled for surgical resection being evaluated at the Hospital of the University of Pennsylvania. * The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf. * The subject must be 18 years of age or older. Exclusion Criteria: * The subject is not able to provide informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.